Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Debt to Equity (2016 - 2022)

Fennec Pharmaceuticals filings provide 10 years of Debt to Equity readings, the most recent being $8.92 for Q3 2022.

  • On a quarterly basis, Debt to Equity changed N/A to $8.92 in Q3 2022 year-over-year; TTM through Sep 2022 was $8.92, a N/A change, with the full-year FY2021 number at $0.32, changed N/A from a year prior.
  • Debt to Equity hit $8.92 in Q3 2022 for Fennec Pharmaceuticals, up from $0.59 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $8.92 in Q3 2022 to a low of $0.32 in Q4 2021.